Spinal Cord Stimulation (SCS) for Neuropathic Pain of Back or Lower Extremity
TerminatedNot applicableNCT00399841
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The primary objective of this study is to compare the efficacy and patient preference for spinal cord stimulation (SCS) using the Precision device with the electrode array placed at T7 versus placement at T8. Eligible patients will have chronic intractable pain in the back or lower extremities and will have independently elected SCS as the next line of therapy. There is some anecdotal evidence that the coverage of the paresthesia resulting from T7 placement is preferable to that obtained by the more commonly used T8 placement but there has been no study to support this observation.
Study details
- Official title
- Spinal Cord Stimulation (SCS) for Neuropathic Pain of Back or Lower Extremity: A Comparison of Electrode Placement at T7 and T8
- Interventions
- Device: Precision for Spinal Cord Stimulation
- Sponsor
- Boston Scientific Corporation
- Start date
- 2006-11
- Primary completion
- 2008-05
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Be diagnosed with chronic intractable neuropathic pain of moderate to severe intensity of the back or lower extremity and meeting the criteria for post-laminectomy syndrome, be eligible for SCS, and have independently elected SCS as next line of therapy. * Be 18 years of age or older. * Be willing and able to comply with all study related procedures and visits. * Be capable of reading and understanding patient information materials and giving written informed consent. Exclusion Criteria: * Have sensory loss in the low back or lower extremity as the primary complaint. * Have any significant medical condition that is likely to interfere with study procedures or likely to confound evaluation of study endpoints. * Have participated in any investigational drug or device trial in the last 4 weeks or plan to participate in any other study during the year.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00399841